US SB1551

Excludes gender transition procedures from the medical expense tax deduction under Internal Revenue Code Section 213, effective for taxable years beginning after enactment

Prohibits federal Medicaid funding for gender transition procedures, including hormonal interventions, puberty blockers, and surgical procedures such as mastectomy, hysterectomy, vaginoplasty, and phalloplasty

Bars federal funding through the Children's Health Insurance Program (CHIP) for gender transition procedures on minors

Prohibits Medicare coverage for gender transition procedures

Excludes gender transition procedures from essential health benefits under the Affordable Care Act, preventing the Secretary of HHS from including such procedures in required coverage

Exempts from the restrictions: treatment for medically verifiable disorders of sex development, treatment of complications from prior gender transition procedures, procedures for physical disorders placing individuals in imminent danger, detransition procedures, puberty blockers for precocious puberty, and male circumcision